Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Spruce Biosciences, Inc. - Common Stock
(NQ:
SPRB
)
44.52
-1.02 (-2.24%)
Delayed Quote
Updated: 10:07 AM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Spruce Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
March 13, 2024
Via
Benzinga
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
February 13, 2024
Pre-market stock movers are a hot topic on Tuesday and we're diving into all of the biggest winners and losers this morning!
Via
InvestorPlace
What 4 Analyst Ratings Have To Say About Spruce Biosciences
↗
November 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 30, 2024
Via
Benzinga
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 30, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia
January 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH
January 05, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Inc. (NASDAQ: SPRB) Making Surprising Moves in Tuesday Session
September 12, 2023
Via
Investor Brand Network
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
January 04, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
November 13, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the Jefferies London Healthcare Conference
November 02, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Analyst Ratings for Spruce Biosciences
↗
September 08, 2023
Via
Benzinga
Expert Ratings for Spruce Biosciences
↗
August 16, 2023
Via
Benzinga
Analyst Expectations for Spruce Biosciences's Future
↗
May 16, 2023
Via
Benzinga
Top 4 Health Care Stocks That May Rocket Higher This Month
↗
October 20, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia
October 18, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
↗
September 08, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
↗
September 08, 2023
Via
Benzinga
Why Smith & Wesson Brands Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
↗
September 08, 2023
Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday.
Via
Benzinga
Adobe To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Friday
↗
September 08, 2023
B of A Securities cut the price target for DigitalOcean Holdings, Inc. (NYSE: DOCN) from $47 to $25. B of A Securities analyst Wamsi Mohan downgraded the stock from Buy to Underperform. DigitalOcean...
Via
Benzinga
Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
August 28, 2023
From
Spruce Biosciences
Via
Business Wire
Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 14, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
July 27, 2023
Via
Benzinga
Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)
June 12, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors
May 25, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences to Participate in the Jefferies Healthcare Conference
May 24, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala
May 22, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 15, 2023
From
Spruce Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
